Sign inJoin waitlistJoin the waitlist

Everett Meyer

Hematology · Stanford Health Care

Credentials: · ·

History

Stanford University Hematology and Oncology Fellowship
Until 2013
Stanford University Internal Medicine Residency
Until 2010
Stanford University Internal Medicine Residency
Until 2009
Stanford University School of Medicine
2008

Research

Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity
Nature Medicine · 2002 · 582 citations
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial
Nature Medicine · 2021 · 534 citations
Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity
Nature Medicine · 2003 · 534 citations

Robert Negrin
47 papers
Robert Lowsky
34 papers
David Miklos
30 papers
Laura Johnston
30 papers
Andrew Rezvani
29 papers
Judith Shizuru
29 papers
Lori Muffly
29 papers
Sally Arai
29 papers
Wen-Kai Weng
28 papers
Matthew Frank
24 papers · 3 as a fellow
Parveen Shiraz
23 papers
Surbhi Sidana
21 papers

Grants

Engineered Immune Cells for T1D
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $3.1M · Stanford University
2022–2026
Bone Marrow Grafting and Cellular Therapy for Leukemia and Lymphoma
National Cancer Institute · P01
Project lead · $2.7M · Stanford University
1997–2025
Therapeutic Targeting of Human Islets with Recombinant Regulatory T Cells
National Institute of Diabetes and Digestive and Kidney Diseases · U01
PI · $2.9M · Stanford University
2019–2023
Blood Stem Cell Transplantation as Immunotherapy
National Heart, Lung, and Blood Institute · P01
Contact PI · $1.7M · Stanford University
2003–2022

Clinical trials

Study of KYV-101 Anti-CD19 CAR T Therapy in Adult Dermatomyositis
Principal investigator · Recruiting · Phase 1
Stanford University
2024–2039
Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft
Principal investigator · Active not recruiting · Phase 1
Stanford University
2021–2028
Donor Regulatory T Cells in Treating Patients With Visceral Acute Graft-versus-Host Disease After Stem Cell Transplant
Principal investigator · Withdrawn · Phase 1
Everett Meyer
2015–2023
A Study of AbGn-168H in Patients With Steroid Refractory Acute Graft-vs-Host Disease After Donor Stem Cell Transplant
Principal investigator · Terminated · Phase 1
AbGenomics B.V Taiwan Branch
2015–2016